Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-25-011978
Filing Date
2025-03-11
Accepted
2025-03-11 16:13:32
Documents
110
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lyel-20241231.htm   iXBRL 10-K 2145559
2 EX-10.22 ex-1022_lyelx20241231x10xk.htm EX-10.22 200919
3 EX-19.1 ex-191_lyelx20241231x10k.htm EX-19.1 60298
4 EX-23.1 ex-231_auditxfirmxconsentx.htm EX-23.1 4665
5 EX-31.1 ex-311_lyelx20241231x10k.htm EX-31.1 10986
6 EX-31.2 ex-312_lyelx20241231x10k.htm EX-31.2 10916
7 EX-32.1 ex-321_lyelx20241231x10k.htm EX-32.1 8059
13 lyel-20241231_g1.jpg GRAPHIC 42979
14 lyel-20241231_g10.jpg GRAPHIC 81620
15 lyel-20241231_g2.jpg GRAPHIC 602051
16 lyel-20241231_g3.jpg GRAPHIC 301689
17 lyel-20241231_g4.jpg GRAPHIC 38080
18 lyel-20241231_g5.jpg GRAPHIC 206221
19 lyel-20241231_g6.jpg GRAPHIC 311354
20 lyel-20241231_g7.jpg GRAPHIC 102504
21 lyel-20241231_g8.jpg GRAPHIC 328095
22 lyel-20241231_g9.jpg GRAPHIC 146132
  Complete submission text file 0001628280-25-011978.txt   16197247

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyel-20241231.xsd EX-101.SCH 74649
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyel-20241231_cal.xml EX-101.CAL 99181
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyel-20241231_def.xml EX-101.DEF 377050
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyel-20241231_lab.xml EX-101.LAB 893859
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyel-20241231_pre.xml EX-101.PRE 658441
113 EXTRACTED XBRL INSTANCE DOCUMENT lyel-20241231_htm.xml XML 1384617
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40502 | Film No.: 25727736
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)